vs
Side-by-side financial comparison of Allot Ltd. (ALLT) and Invivyd, Inc. (IVVD). Click either name above to swap in a different company.
Allot Ltd. is the larger business by last-quarter revenue ($24.1M vs $17.2M, roughly 1.4× Invivyd, Inc.). Allot Ltd. runs the higher net margin — -7.0% vs -64.3%, a 57.3% gap on every dollar of revenue. On growth, Invivyd, Inc. posted the faster year-over-year revenue change (24.5% vs 8.5%).
Allot Ltd., formerly Allot Communications, is an Israeli high-tech company that develops telecommunications software. The company is headquartered in Hod Hasharon, Israel.
Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.
ALLT vs IVVD — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.1M | $17.2M |
| Net Profit | $-1.7M | $-11.1M |
| Gross Margin | 72.1% | — |
| Operating Margin | -1.7% | -73.0% |
| Net Margin | -7.0% | -64.3% |
| Revenue YoY | 8.5% | 24.5% |
| Net Profit YoY | 49.6% | 40.0% |
| EPS (diluted) | $-0.04 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $17.2M | ||
| Q3 25 | — | $13.1M | ||
| Q2 25 | $24.1M | $11.8M | ||
| Q1 25 | $23.1M | $11.3M | ||
| Q4 24 | — | $13.8M | ||
| Q3 24 | — | $9.3M | ||
| Q2 24 | $22.2M | $2.3M | ||
| Q1 24 | — | $0 |
| Q4 25 | — | $-11.1M | ||
| Q3 25 | — | $-10.5M | ||
| Q2 25 | $-1.7M | $-14.7M | ||
| Q1 25 | $-332.0K | $-16.3M | ||
| Q4 24 | — | $-18.4M | ||
| Q3 24 | — | $-60.7M | ||
| Q2 24 | $-3.4M | $-47.2M | ||
| Q1 24 | — | $-43.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 72.1% | — | ||
| Q1 25 | 69.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 68.5% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | -73.0% | ||
| Q3 25 | — | -84.0% | ||
| Q2 25 | -1.7% | -127.8% | ||
| Q1 25 | -3.1% | -149.7% | ||
| Q4 24 | — | -139.1% | ||
| Q3 24 | — | -670.0% | ||
| Q2 24 | -15.2% | -2175.2% | ||
| Q1 24 | — | — |
| Q4 25 | — | -64.3% | ||
| Q3 25 | — | -79.7% | ||
| Q2 25 | -7.0% | -124.4% | ||
| Q1 25 | -1.4% | -144.1% | ||
| Q4 24 | — | -133.5% | ||
| Q3 24 | — | -653.1% | ||
| Q2 24 | -15.1% | -2086.9% | ||
| Q1 24 | — | — |
| Q4 25 | — | $0.02 | ||
| Q3 25 | — | $-0.06 | ||
| Q2 25 | $-0.04 | $-0.12 | ||
| Q1 25 | $-0.01 | $-0.14 | ||
| Q4 24 | — | $-0.14 | ||
| Q3 24 | — | $-0.51 | ||
| Q2 24 | $-0.09 | $-0.40 | ||
| Q1 24 | — | $-0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.1M | $226.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $99.7M | $241.5M |
| Total Assets | $154.1M | $276.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $226.7M | ||
| Q3 25 | — | $85.0M | ||
| Q2 25 | $60.1M | $34.9M | ||
| Q1 25 | $10.1M | $48.1M | ||
| Q4 24 | — | $69.3M | ||
| Q3 24 | — | $106.9M | ||
| Q2 24 | $15.9M | $147.9M | ||
| Q1 24 | — | $189.4M |
| Q4 25 | — | $241.5M | ||
| Q3 25 | — | $93.1M | ||
| Q2 25 | $99.7M | $42.8M | ||
| Q1 25 | $50.0M | $54.1M | ||
| Q4 24 | — | $67.5M | ||
| Q3 24 | — | $83.2M | ||
| Q2 24 | $46.7M | $140.6M | ||
| Q1 24 | — | $178.5M |
| Q4 25 | — | $276.9M | ||
| Q3 25 | — | $139.2M | ||
| Q2 25 | $154.1M | $89.1M | ||
| Q1 25 | $140.3M | $103.7M | ||
| Q4 24 | — | $129.5M | ||
| Q3 24 | — | $161.9M | ||
| Q2 24 | $132.5M | $177.3M | ||
| Q1 24 | — | $215.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $-15.5M |
| Free Cash FlowOCF − Capex | $4.0M | — |
| FCF MarginFCF / Revenue | 16.5% | — |
| Capex IntensityCapex / Revenue | 1.7% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-6.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-15.5M | ||
| Q3 25 | — | $-8.3M | ||
| Q2 25 | $4.4M | $-13.3M | ||
| Q1 25 | $1.7M | $-21.1M | ||
| Q4 24 | — | $-37.6M | ||
| Q3 24 | — | $-41.1M | ||
| Q2 24 | $1.2M | $-41.6M | ||
| Q1 24 | — | $-50.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $4.0M | $-13.3M | ||
| Q1 25 | $1.4M | $-21.3M | ||
| Q4 24 | — | $-37.6M | ||
| Q3 24 | — | $-41.1M | ||
| Q2 24 | $217.0K | — | ||
| Q1 24 | — | $-50.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 16.5% | -112.9% | ||
| Q1 25 | 6.1% | -188.2% | ||
| Q4 24 | — | -272.2% | ||
| Q3 24 | — | -441.6% | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | 1.7% | 0.1% | ||
| Q1 25 | 1.2% | 1.3% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | 4.3% | 0.0% | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
